EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial

Amber B Courville iD, Sharon Majchrzak-Hong, Shanna Yang, Sara Turner, Breanne Wilhite, Katherine Ness Shipley, Yvonne Horneffer, Anthony F Domenichiello iD, Melanie Schwandt, Roy G Cutler, Kong Y Chen, Joseph R Hibbeln und 1 weitere

Lipids · 2023

DOI: 10.1002/lipd.12382 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lipids, 2023. Verfasst von Amber B Courville und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Linoleic Acid, Endocannabinoids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIAAA NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The linoleic acid (LA)‐arachidonic acid (ARA)‐inflammatory axis suggests dietary LA lowering benefits health because it lowers ARA and ARA‐derived endocannabinoids (ECB). Dietary LA reduction increases concentrations of omega‐3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and DHA derived ECB. The aim of this study was to examine targeted reduction of dietary LA, with and without EPA and DHA, on plasma EPA and DHA and ECB (2‐arachidonoyl glycerol [2‐AG], anandamide [AEA], and docosahexaenoyl ethanolamide [DHA‐EA]). Healthy, pre‐menopausal women ( n = 62, BMI 30 ± 3 kg/m 2 , age 35 ± 7 years; mean ± SD) were randomized to three 12‐week controlled diets: (1) high LA, low omega‐3 EPA and DHA (H6L3); (2) low LA, low omega‐3 EPA and DHA (L6L3); or (3) low LA, high omega‐3 EPA and DHA (L6H3). Baseline plasma fatty acids and ECB were similar between diets. Starting at 4 weeks, L6L3 and L6H3 lowered plasma LA compared to H6L3 ( p < 0.001). While plasma ARA changed from baseline by 8% in L6L3 and −8% in L6H3, there were no group differences. After 4 weeks, plasma EPA and DHA increased from baseline in women on the L6H3 diet ( p s < 0.001) and were different than the H6L3 and L6L3 diets. No differences were found between diets for AEA or 2‐AG, however, in L6L3 and L6H3, AEA increased by 14% ( p s < 0.02). L6H3 resulted in 35% higher DHA‐EA ( p = 0.013) whereas no changes were seen with the other diets. Lowering dietary LA did not result in the expected changes in fatty acids associated with the LA‐ARA inflammatory axis in women with overweight and obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Linoleic AcidEndocannabinoidsHumansFemaleAdultArachidonic AcidOverweightDietDocosahexaenoic AcidsFatty AcidsEicosapentaenoic AcidObesityArachidonic Acids

Stichwörter der Autor:innen

arachidonic aciddietdocosahexaenoic acideicosapentaeonic acidendocannabinoidlinoleic acid

Substanzen

Linoleic AcidArachidonic AcidEndocannabinoidsDocosahexaenoic AcidsFatty AcidsEicosapentaenoic AcidArachidonic Acids

Autor:innen und Institutionen

  • National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
  • National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
  • National Institutes of Health, Clinical Center, Bethesda, Maryland, USA.
  • National Institutes of Health, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
  • National Institutes of Health, National Institute on Aging, Bethesda, Maryland, USA.

ORCID-Profile: Amber B Courville, Anthony F Domenichiello, Christopher E Ramsden

Förderung

  • Intramural NIH HHS
  • NIAAA NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Aging
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Courville, A. B., Majchrzak-Hong, S., Yang, S., Turner, S., Wilhite, B., Ness Shipley, K., Horneffer, Y., Domenichiello, A. F., Schwandt, M., Cutler, R. G., Chen, K. Y., Hibbeln, J. R., & Ramsden, C. E. (2023). Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial. Lipids. https://doi.org/10.1002/lipd.12382

Vancouver

Courville AB, Majchrzak-Hong S, Yang S, Turner S, Wilhite B, Ness Shipley K, et al. Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial. Lipids. 2023. doi:10.1002/lipd.12382

BibTeX
@article{Courville2023,
  author = {Courville, Amber B and Majchrzak-Hong, Sharon and Yang, Shanna and Turner, Sara and Wilhite, Breanne and Ness Shipley, Katherine and Horneffer, Yvonne and Domenichiello, Anthony F and Schwandt, Melanie and Cutler, Roy G and Chen, Kong Y and Hibbeln, Joseph R and Ramsden, Christopher E},
  title = {Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial},
  journal = {Lipids},
  year = {2023},
  doi = {10.1002/lipd.12382}
}
Kostenlos starten →